• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Optinose Inc (NQ: OPTN )

    1.030 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 81
    Open 1.030
    Bid (Size) 0.8400 (94)
    Ask (Size) 1.130 (40)
    Prev. Close 1.030
    Today's Range 1.030 - 1.030
    52wk Range 0.8000 - 2.100
    Shares Outstanding 53,309,012
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    From Optinose, Inc.
    Via GlobeNewswire
    OPTN Stock Earnings: OptiNose Beats EPS, Misses Revenue for Q2 2024
    OPTN stock results show that OptiNose beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -17.60%
    -17.60%
    1 Month
    -2.83%
    -2.83%
    3 Month
    -3.74%
    -3.74%
    6 Month
    -43.25%
    -43.25%
    1 Year
    -18.90%
    -18.90%

    More News

    Read More
    Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights
    From Optinose, Inc.
    Via GlobeNewswire
    Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
    From Optinose, Inc.
    Via GlobeNewswire
    7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million
    Via InvestorPlace
    Expanded Access to XHANCE with Addition to National Commercial Formularies
    From Optinose, Inc.
    Via GlobeNewswire
    Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
    From Optinose, Inc.
    Via GlobeNewswire
    Why Doximity Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    OPTN Stock Earnings: OptiNose Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
    From Optinose, Inc.
    Via GlobeNewswire
    Optinose Announces Reporting Date for First Quarter 2024 Financial Results
    From Optinose, Inc.
    Via GlobeNewswire
    Optinose Announces $55 Million Registered Direct Offering
    From Optinose, Inc.
    Via GlobeNewswire
    Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    Why Are Stocks Down Today?
    Via InvestorPlace
    Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Is OptiNose (OPTN) Stock Up 12% Today?
    Via InvestorPlace
    Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
    From Optinose, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Optinose to Present at the Needham Virtual Healthcare Conference
    From Optinose, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
    From Optinose, Inc.
    Via GlobeNewswire
    OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
    From Optinose, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 7, 2024
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.